Hypnotizability and Gut-Directed Hypnotherapy: Am I Hypnotizable Enough?

This page walks through what hypnotizability actually is, where the population falls on the spectrum, what the clinical research says about hypnotizability and gut-directed hypnotherapy (GDH) response, and what to do if you suspect you sit on the low end. Every figure here is from published research on standardised susceptibility scales or on GDH outcomes.

Hypnotizability (also called hypnotic susceptibility, hypnotic responsiveness, or in older literature suggestibility) is a measurable, relatively stable individual trait. It reflects how readily a person enters and uses a focused, absorbed state of attention in response to standardised verbal cues. The trait has been studied rigorously since the 1950s, primarily through two instruments developed at Stanford and Harvard.

The Stanford Hypnotic Susceptibility Scale (SHSS), in its most used Form C, is a 12-item structured procedure administered one-on-one by a trained examiner. The examiner delivers a standardised induction and then issues 12 specific suggestions of escalating difficulty. Items range from simple motor suggestions (eye closure, hand lowering) through cognitive suggestions (positive hallucination of a fly, age regression) to challenge items at the high end. The examiner scores each item objectively. The total score (0-12) places the person in low (0-3), medium (4-7), or high (8-12) susceptibility ranges.

The Harvard Group Scale of Hypnotic Susceptibility is the group-administered analogue, used in research and population studies. Scores correlate strongly with the SHSS and produce the same broad distribution. The Tellegen Absorption Scale (a self-report measure of imaginative absorption) is often used as a proxy because it is easier to administer and correlates moderately with measured hypnotizability.

Two practical points worth understanding before going further. First, hypnotizability as measured by these scales is relatively stable across the lifespan. Test-retest correlations over decades are high. It is not a mood, an attitude, or a willingness to cooperate. It is a trait. Second, that trait is not the same thing as wanting to be hypnotized or believing in it. Sceptics with high measured hypnotizability still respond. Believers with low measured hypnotizability still struggle. The trait predicts above and beyond belief and motivation.

A useful related construct is imaginative absorption, captured in the Tellegen Absorption Scale. Absorption refers to the tendency to become deeply involved in sensory or imaginal experiences, losing track of time, and experiencing imagined content with near-perceptual vividness. Absorption correlates moderately with measured hypnotizability and is what most online self-screens (including ours) actually tap. It is not a perfect proxy, but it gives a directional read in 60 seconds rather than 60 minutes.

Neuroimaging research over the past two decades has begun to map the brain correlates of hypnotic responsiveness. High-hypnotizable individuals show differences in the connectivity between executive control networks and the default mode network during hypnotic induction, along with altered activity in the dorsolateral prefrontal cortex and the insula. Low responders show less differentiation between baseline attention and induced hypnotic attention. None of this changes the clinical bottom line for IBS, but it situates hypnotizability as a real neurobiological trait rather than a personality quirk.

Across decades of population studies using the Stanford and Harvard scales, the distribution of hypnotizability in the general adult population is well characterised. It looks roughly like this:

• Low hypnotizability (~10-15%). SHSS scores of 0-3. People in this band pass few or no items beyond the simplest motor suggestions. They often report feeling unchanged during induction and finding the experience difficult to engage with. This is the band where classic protocol effects are weakest.
• Moderate hypnotizability (~70-80%). SHSS scores of 4-7. The large majority of the population. People in this band report a noticeable shift in attention, can engage with most suggestions, and respond reliably to clinical hypnotherapy protocols including GDH. This is where the bulk of documented clinical response lives.
• High hypnotizability (~10-15%). SHSS scores of 8-12. People in this band engage vividly and easily, respond to challenge items including positive hallucination and age regression, and tend to show the strongest and fastest GDH responses on average.

Two important properties of this distribution. It is approximately normally shaped with most people clustered in the middle, and it is relatively stable across cultures and decades. The same broad 10/80/10 pattern appears in studies from the United States, the United Kingdom, Continental Europe, and Australia, across multiple research generations. This is why the headline reassurance (“most people are hypnotizable enough”) holds up so consistently. It is not optimism; it is the population data.

A note on age and gender. Hypnotizability tends to peak in childhood and adolescence, and gradually drift slightly downward across adulthood, though most adults remain in the same broad band they occupied at age 20. Gender differences are small and inconsistent across studies. Education, income, ethnicity, and religious orientation show essentially no relationship with measured hypnotizability. The trait cuts across demographic lines in a way few psychological variables do.

A note on the band labels themselves. The Stanford and Harvard cutoffs (low 0-3, medium 4-7, high 8-12 on the 12-item scales) are research conventions, not hard biological boundaries. A score of 4 is functionally similar to a score of 3, and a score of 8 is functionally similar to a score of 7. The labels are useful shorthand for talking about the spectrum, but the underlying construct is continuous. People near the band boundaries should treat the label loosely.

Yes, modestly. Hypnotizability is a real and replicated predictor of response to gut-directed hypnotherapy, but it is not a hard cutoff and it does not override the other contributors (engagement, protocol fidelity, severity, comorbidities, practitioner fit). Three things are true at once.

First, higher hypnotizability is associated with stronger and faster response on average. People in the high band tend to notice change earlier in the protocol and report larger reductions in IBS symptom severity by end of treatment. This pattern shows up across multiple GDH research samples and is consistent with what hypnotherapy researchers see in non-IBS contexts (pain, anxiety, smoking cessation).

Second, moderate hypnotizability is sufficient for clinically meaningful response. The Manchester Protocol audit (Miller 2015, PMID 25736234) reported 76% response across 1,000 IBS patients without selecting for high hypnotizability. Given the population distribution, most of those 1,000 patients were in the moderate band, not the high band. The protocol was designed to work in the moderate range because that is where most of the population sits.

Third, low hypnotizability is associated with weaker response, but it is not predictive of zero response. People in the low band sometimes do respond, particularly when the protocol is adapted (more cognitive framing, less pure imagery; more behavioural homework, less open-ended absorption). And people in the high band sometimes do not respond, often because something else is driving symptoms (a missed structural cause, an untreated trauma, a comorbid anxiety disorder).

The empirical question (do hypnotizability scores predict who responds to GDH for IBS?) has been examined in multiple GDH trials, though hypnotizability has rarely been the primary outcome variable. Walking through the relevant evidence:

• Whorwell 1984 (The Lancet). The original randomised controlled trial of GDH for IBS. Whorwell and colleagues did not preselect for hypnotizability; they enrolled severely refractory patients regardless. The dramatic symptom improvement in the GDH arm relative to supportive psychotherapy controls demonstrated that meaningful response was achievable across an unselected refractory IBS sample.
• Miller 2015 (PMID 25736234). The 1,000-patient Manchester audit reported 76% response without selecting for hypnotizability. The authors note that response rates were broadly consistent across patient subgroups, supporting the interpretation that the protocol works across the moderate-to-high range that contains most of the population.
• Peters 2016 (PMID 27397586). The randomised comparison of GDH to the low-FODMAP diet enrolled an unselected IBS sample and found equivalent GI outcomes plus superior psychological outcomes for the GDH arm. Again, no hypnotizability preselection.
• Hasan 2019 (PMID 30702396). The face-to-face vs telehealth comparison reported 76% in-person and 65% via live Skype, on the same Manchester Protocol. Population was unselected for hypnotizability. The fact that both arms produced strong response argues that the active mechanism (live clinician guidance) operates effectively across the moderate-to-high responsiveness range.
• Specific hypnotizability research. Across the broader hypnotherapy literature (not specific to IBS), hypnotizability correlates modestly but reliably with treatment response in pain, anxiety, and other applications. Effect sizes are typically small-to-moderate, meaning hypnotizability accounts for some, but not most, of the variance in who responds.

The summary the literature supports: hypnotizability is a real predictor but a modest one. It is not the dominant variable. Engagement, protocol fidelity, severity, comorbidities, and practitioner skill all weigh in. This is why the responsible read of a quiz score is “useful information for expectations,” not “binding prediction of outcome.”

A useful framing comes from the broader hypnotherapy and pain literature. Hypnotizability tends to account for roughly 10-25% of the variance in treatment response across applications studied. That is a real, replicated effect, and large enough to matter clinically. It also leaves 75-90% of the variance to everything else: how skilled the clinician is at pacing and adapting, how actively the patient practices between sessions, whether comorbid anxiety or depression is being addressed in parallel, whether the underlying IBS presentation has a structural component that GDH cannot reach. These other variables are mostly modifiable, which is why response rates can be improved with attention to them even when hypnotizability is fixed.

One more nuance. The relationship between hypnotizability and GDH response may be partly mediated by adherence rather than by direct mechanism. People who find themselves naturally absorbed in the home audio practice listen more often, engage more deeply, and progress faster through the protocol. People who find the practice harder to engage with skip sessions, lose momentum, and accumulate less protocol exposure. Some of the apparent “hypnotizability predicts response” signal is really “hypnotizability predicts adherence, which predicts response.” This is good news for the low band: deliberate adherence supports (clinician check-ins, practice scheduling, accountability structures) can offset some of the trait disadvantage.

The reason the “am I hypnotizable enough?” question almost always resolves in the patient’s favour comes down to two facts taken together.

Fact one: the population distributes mostly in the moderate band. Roughly 70-80% of the adult population scores in the medium hypnotizability range on standardised testing. Add the high band, and you are at roughly 85% in the clinically responsive range. Only about 10-15% sit in the low band where classic protocol effects are weakest. Statistically, you are almost certainly in the workable range.

Fact two: clinical GDH protocols were designed for the moderate band. The Manchester Protocol, the UNC Protocol, and modern adaptations were not calibrated to require the highest susceptibility scores. They were calibrated to work for the bulk of the IBS population, which lives in the same moderate band as the general population. The 76% response rate Miller 2015 reported is the response rate of an unselected sample, which is functionally the response rate of the moderate band.

A useful proxy: people who can get absorbed in a novel, lose track of time watching a film, drive a familiar route on autopilot, or get pulled into vivid daydreams are almost certainly in the moderate-to-high band. People who use guided meditation apps and find the visualisations generate real bodily sensation are in the band. People who have ever had a vivid memory bring back a physical feeling (a smell of a place, the warmth of a remembered embrace) are in the band.

If your quiz score sits on the low end, or if previous attempts at hypnotherapy or guided meditation have left you feeling unchanged, the question becomes practical: what is the best path forward? Several things are worth considering in parallel.

The 3-session commitment as an empirical test. Self-report quizzes are imperfect. Some people who score low on a screen turn out to engage well in a clinical setting where the induction is paced and personalised. The 3 sessions cost less than a full protocol and will surface your actual response pattern empirically. If you are responding, you continue. If you are not, you have lost less than the price of a 12-session block.

Hypnotizability can be partially trained. Studies on skills training (notably the Carleton Skills Training Programme and successors) show that brief structured training plus practice can shift measured hypnotizability upward, particularly in the low-to-moderate range. This shift is not unlimited (a person scoring 1 does not become a 10), but a 1-3 point increase on the Stanford scale is achievable for many people. Built-in home audio practice in the Manchester Protocol provides exactly this kind of repeated exposure.

Adapted protocols for the low responsiveness range. A skilled clinician can shift the protocol toward more cognitive framing, more behavioural homework, and less reliance on pure imagery for low responders. This will not match the response rate of the moderate band, but it materially improves outcomes in the low band relative to a one-size-fits-all script.

Alternative or complementary approaches with comparable evidence. CBT-for-IBS has a comparable evidence base to GDH and works through different mechanisms (cognitive restructuring of catastrophic interpretations, behavioural exposure to feared foods or situations). The low-FODMAP diet, properly supervised by a Monash-trained registered dietitian, produced equivalent GI outcomes to GDH in Peters 2016. Mindfulness-based stress reduction, biofeedback, and pelvic floor physiotherapy (where indicated) all have roles. None of these require hypnotizability.

The honest framing: low hypnotizability is not a verdict that you cannot get better. It is information that GDH may not be the optimal first-line route for you, that the response curve may be slower or smaller, and that holding GDH in parallel with other approaches is worth considering. Anyone who pushes you into a 12-session GDH commitment based on a quiz alone is not reading the evidence honestly.

A reasonable sequence for someone scoring on the low end. Start with the 3-session commitment so you have direct empirical data on your own response rather than predictive guesswork. While doing it, build a parallel conversation with a registered dietitian about whether a structured low-FODMAP trial makes sense for your symptom profile. If response by session 3 is weak, the 3 sessions still leave you better informed about what is and is not driving symptoms, and the next step (CBT-for-IBS, dietary work, gastroenterology workup, or extended hypnotherapy with adapted methods) is chosen based on actual data rather than a guess. This sequence applies to anyone uncertain about responsiveness, but it is particularly valuable for the low-end band.

Beyond the formal quiz, several lived-experience indicators correlate well with falling in the moderate-to-high responsiveness band. The more of these you recognise in yourself, the more likely you sit in the band where GDH protocols produce their strongest effects.

These indicators are not a diagnostic, and missing several of them does not mean you are in the low band (some people compartmentalise their absorption tightly and underestimate it). They are a directional signal. If you recognise five or more of these in yourself, your odds of being in the moderate-to-high band are very high. If you recognise one or two, take the quiz; the answer may surprise you.

The quiz embedded near the top of this page is a 60-second self-report screen drawn from items used in the absorption and responsiveness scales (the Tellegen Absorption Scale and the items shared between the Stanford and Harvard instruments). It is not the formal SHSS, which requires a trained examiner and 40-60 minutes. It is a triage tool.

What the quiz can do well: place you in a broad band (low, moderate, or high), give you a directional read on your likely GDH responsiveness, and frame realistic expectations going into a first session. What it cannot do: replace the empirical test of actually trying the protocol. People who score in the moderate band sometimes turn out to be high responders, and vice versa.

We have built the quiz this way deliberately. A long quiz that pretends to be a clinical instrument is misleading; a 60-second screen that gives you directional information without overclaiming is honest. The right way to use it is as a conversation starter, not as a gate. You can take it on the dedicated quiz page with more context, or directly above on this page.

Almost every prospective IBS hypnotherapy client carries at least one misconception about hypnotizability into the conversation. Here are the most common ones, and what the evidence actually says.

Myth 1: I will lose control. Clinical hypnotherapy is not stage hypnosis. You are aware throughout, can hear and respond, and cannot be made to do anything against your values or judgement. The state used in GDH is closer to the absorbed focus of being engrossed in a book than to anything resembling unconsciousness. Loss-of-control reports come overwhelmingly from stage performance contexts where social pressure plays a role.

Myth 2: Highly hypnotizable people are weak-willed or gullible. Decades of personality research show no correlation between hypnotizability and weak will, gullibility, or low intelligence. High hypnotizability correlates with imaginative absorption, focused attention, and creativity. The trait sits comfortably alongside high intelligence and high agency.

Myth 3: I am too rational or too smart to be hypnotized. The research shows no relationship between general intelligence and hypnotizability. Plenty of scientists, engineers, lawyers, and other highly analytic people respond strongly to clinical hypnotherapy. Sceptical analytic engagement does not preclude responsiveness; it sometimes correlates with it (because focused attention is a shared substrate).

Myth 4: Hypnotizability is the same as suggestibility. They overlap but they are not identical. Suggestibility refers to a broader tendency to accept persuasive information; hypnotizability is a specific trait concerning absorbed engagement with imaginative cues. Many people who score low on general suggestibility (sceptical, contrarian, hard to persuade) score in the moderate or high band on hypnotizability.

The practical consequence: do not let any of these myths talk you out of trying a 3-session block. The research suggests roughly 85% of you are in the responsive band, and the only way to find out which side of the line you are on is to try.

One more myth worth naming, because it specifically interferes with the IBS conversation: the idea that hypnotherapy means “it is all in your head”. It does not. Gut-directed hypnotherapy works on a real, measurable physical process: visceral hypersensitivity, the dialled-up signalling between gut and brain that is documented in IBS using rectal barostat studies, fMRI of the insula and anterior cingulate, and gut motility measurement. The fact that a psychological intervention can shift a physical signalling pattern does not mean the signalling pattern was imaginary. It means the brain participates in gut function, which is uncontroversial in modern gastroenterology. GDH targets a real mechanism; hypnotizability is a trait that determines how readily a particular individual can engage that mechanism using the protocol’s methods.